Solbec patients want another dose

By Staff Reporters

14/09/2004 - 22:00

SOME patients taking part in phase 1 trials of Solbec Pharmaceuticals anti-cancer drug SBP002 have asked to continue taking the drug.

To read our articles you will need to either login or subscribe.

Your single user subscription provides more than you think